Latest Breaking News On - News ratings for catalyst pharmaceuticals daily - Page 1 : comparemela.com

Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Insider Sells $121,183 87 in Stock

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) insider Carmen Jeffrey Del sold 7,541 shares of the company’s stock in a transaction on Friday, June 7th. The stock was sold at an average price of $16.07, for a total transaction of $121,183.87. Following the completion of the sale, the insider now owns 18,427 shares of […]

United statesKennedy capital managementCatalyst pharmaceuticals stock performanceVanguard group incCantor fitzgeraldInstitutional investors weigh in on catalyst pharmaceuticalsQuarter for catalyst pharmaceuticalsJanus henderson groupCatalyst pharmaceuticals company profileNews ratings for catalyst pharmaceuticals dailyCatalyst pharmaceuticalsCatalyst pharmaceuticals incMesirow institutional investment management incGet free reportCarmen jeffrey delHenderson group

Catalyst Pharmaceuticals (NASDAQ:CPRX) Upgraded to Buy by StockNews com

Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Friday. Several other analysts also recently commented on CPRX. Oppenheimer reaffirmed an “outperform” rating and set a $29.00 target price on shares of Catalyst Pharmaceuticals in a […]

United statesGary ingenitoBrian elsberndDekabank deutsche girozentraleCatalyst pharmaceuticalsAnalyst recommendations for catalyst pharmaceuticalsCatalyst pharmaceuticals company profileCatalyst pharmaceuticals incSecurities exchange commissionCantor fitzgeraldCetera advisorsCatalyst pharmaceuticals stock performanceNews ratings for catalyst pharmaceuticals dailyInstitutional investors weigh in on catalyst pharmaceuticalsComerica bankVirtu financial

Gallacher Capital Management LLC Has $245,000 Holdings in Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX)

Gallacher Capital Management LLC Has $245,000 Holdings in Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesDavids tierneyCerity partnersParkside financial bankNews ratings for catalyst pharmaceuticals dailyRaymond james associatesCantor fitzgeraldGallacher capital managementCatalyst pharmaceuticals profileBoard of administration florida retirement systemCatalyst pharmaceuticalsExchange commissionSecurities exchange commissionCatalyst pharmaceuticals price performanceCatalyst pharmaceuticals incQuarter for catalyst pharmaceuticals

Summit Global Investments Lowers Stake in Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX)

Summit Global Investments Lowers Stake in Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesBrian elsberndSherbrooke park advisersFinancial services group incCantor fitzgeraldNews ratings for catalyst pharmaceuticals dailyCatalyst pharmaceuticals stock performanceNisa investment advisorsParkside financial bankInsider activity at catalyst pharmaceuticalsSecurities exchange commissionCatalyst pharmaceuticals incHoldings channelCatalyst pharmaceuticalsQuarter for catalyst pharmaceuticalsSummit global investments

Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Given Average Rating of Buy by Brokerages

Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Given Average Rating of Buy by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesDavids tierneyCatalyst pharmaceuticals incNews ratings for catalyst pharmaceuticals dailyParkside financial bankSherbrooke park advisersCatalyst pharmaceuticals company profileCatalyst pharmaceuticalsTower research capitalCatalyst pharmaceuticals price performanceInsider transactions at catalyst pharmaceuticalsCantor fitzgeraldInstitutional trading of catalyst pharmaceuticalsAnalyst recommendations for catalyst pharmaceuticalsNisa investment advisorsGet free report